Here, we show that the human homologue of the Caenorhabditis elegans biological clock protein CLK-2 (HCLK2) associates with the S-phase checkpoint components ATR, ATRIP, claspin and Chk1. Consistent with a critical role in the S-phase checkpoint, HCLK2-depleted cells accumulate spontaneous DNA damage in S-phase, exhibit radio-resistant DNA synthesis, are impaired for damage-induced monoubiquitination of FANCD2 and fail to recruit FANCD2 and Rad51 (critical components of the Fanconi anaemia and homologous recombination pathways, respectively) to sites of replication stress. Although Thr 68 phosphorylation of the checkpoint effector kinase Chk2 remains intact in the absence of HCLK2, claspin phosphorylation and degradation of the checkpoint phosphatase Cdc25A are compromised following replication stress as a result of accelerated Chk1 degradation. ATR phosphorylation is known to both activate Chk1 and target it for proteolytic degradation, and depleting ATR or mutation of Chk1 at Ser 345 restored Chk1 protein levels in HCLK2-depleted cells. We conclude that HCLK2 promotes activation of the S-phase checkpoint and downstream repair responses by preventing unscheduled Chk1 degradation by the proteasome.
The DNA damage response (DDR) is a complex process involving the orchestration of highly specialized cell-cycle checkpoints that need to be rapidly activated following the detection of damaged DNA. Each of these signalling cascades involves several unique and overlapping factors -classified as sensors, mediators, transducers and effectors -that ultimately lead to the spatio-temporal assembly of multi-protein complexes at the site of damage 1, 2 . The functional importance of checkpoints in maintaining genome stability is highlighted by their conservation throughout eukaryotes. As such, defective checkpoint pathways in human cells leads to the accumulation of aberrant DNA and an increased risk of cancer progression, evident from the many human disease syndromes that result from defects in checkpoint factors 3, 4 . Therefore, it is important to understand these complex mechanisms at the molecular level to further our knowledge of cancer progression and treatment.
Checkpoints operate at the G1-S, S and G2-M boundaries of the cell cycle and are controlled by the ATM-Chk2 and ATR-Chk1 pathways. The S-phase checkpoint, which is under the control of the ATR-Chk1 pathway, has an essential role in maintaining replication-fork integrity during normal S-phase by preventing the collapse of stalled replication forks. The S-phase checkpoint also coordinates cell-cycle arrest and subsequent DNA-repair events when the replication fork encounters DNA damage 5, 3, 6 . Activation and recruitment of the Fanconi anaemia and homologous recombination-repair pathways to sites of replication stress requires an intact S-phase checkpoint 7 .
Recent work in mouse models has highlighted a surprising, yet highly important link between biological clock proteins and the DDR 8, 9 . It has been shown that two clock proteins, Per1 and Prd4, have integral roles in the ATM-Chk2 DDR pathway 10, 11 . Here, we show that HCLK2, an uncharacterized orphan mammalian protein with weak similarity to the C. elegans biological clock protein CLK-2, interacts with components of the S-phase checkpoint and has a critical role in this checkpoint and the subsequent activation of both Fanconi anaemia and homologousrecombination repair responses.
RESULTS

HCLK2 interacts with components of the S-phase checkpoint
Studies of C. elegans clk-2 mutants suggest that CLK-2 has an undetermined role in checkpoint responses to genotoxic stress 12, 13 . A putative homologue of CLK-2 from the human genome (HCLK2; KIAA068) possesses weak homology to the C. elegans protein within a central core of 550 amino acids (Fig. 1a) . Polyclonal antibodies that specifically recognise endogenous and transfected HA-Flag-HCLK2, and are capable of immunoprecipitating HCLK2 from cell extracts, were developed to investigate HCLK2 function (Fig. 1b) . The band detected by western blotting is depleted using HCLK2 small interfering RNAs (siRNAs; Fig. 1b) .
A combination of mass spectrometry and western blotting identified the checkpoint kinase ATR as a factor that immunoaffinity copurifies with endogenous HCLK2 from HeLa extracts (Fig. 1c) . The association of HCLK2 and ATR was confirmed with two independently derived HCLK2 antibodies ( Fig. 1d and see Supplementary Information, Fig. S1a ). HCLK2 and ATRIP, a known ATR interacting partner 5 , coimmunoprecipitated with ATR antibodies (Fig. 1e) . Reciprocal coimmunoprecipitation of HCLK2 and ATRIP was also detected ( Fig. 1f and see Supplementary Information, Fig. S1b ). Furthermore, a weak but reproducible interaction between HCLK2, claspin and Chk1 was observed that was enhanced with hydroxyurea treatment (Fig. 1g and see Supplementary Information, Fig. S1c ). Although HCLK2 and Chk1 reciprocally coimmunoprecipitated, HCLK2 was not reproducibly detected in claspin immunoprecitates, which could be due to epitope masking ( Fig. 1g and see Supplementary Information, Fig. S1c ). Interactions between HCLK2 and the 9-1-1 complex or with the homologous-recombination factor Rad51 were not observed under any conditions tested (data not shown). These results raise the possibility that HCLK2 directly functions in the S-phase checkpoint, analogous to its C. elegans counterpart 12, 13 . HCLK2 prevents spontaneous DNA damage and is required for intra-S-phase arrest after DNA damage The S-phase checkpoint has a critical role in preventing spontaneous replication-fork collapse during unperturbed S-phase 14 . After ATR or HCLK2 depletion (Fig. 2a) , approximately 35% of cells exhibit extensive focus formation of the ssDNA-binding protein sub-unit RPA32 under non-challenged conditions, compared with 5% of cells with control siRNA (Fig. 2b, c) . Furthermore, ubiquitination events mediated by the breast cancer tumour suppressor protein BRCA1, triggered by single-strand DNA (ssDNA) accumulation in S-phase 15 , are also induced in 15% of HCLK2-depleted cells compared with 2% of cells with control siRNA (Fig. 2b, c 
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Chk1 HU: spontaneous DNA damage; see Supplementary Information, Fig. S2 ). Furthermore, γH2AX and ATR foci are also elevated in the absence of HCLK2 (see Supplementary Information, Fig. S2a, b) . Previous studies have shown that deficiency in the topoisomerase II binding protein, TopBP1, leads to aberrant mitosis 17 . Indeed, depletion of HCLK2 or Chk1 resulted in a pronounced increase in abnormal mitoses (Fig. 2d) . These data suggest that HCLK2 facilitates replication-fork progression and prevents the accumulation of DNA damage during normal S-phase [16] [17] [18] . The S-phase checkpoint is also responsible for inhibiting S-phase progression after DNA damage. Radio-resistant DNA synthesis (RDS) is a hallmark of S-phase checkpoint deficiency and can be measured by incorporation of tritiated thymidine before and in response to DNA damage 19 . Control siRNA-treated cells exhibited a decrease of approximately 60% in the rate of DNA synthesis in response to irradiationinduced DNA damage (Fig. 2e) . In contrast, cells treated with HCLK2 or ATR siRNA displayed an RDS phenotype with less than 20% reduction in the rate of DNA synthesis after irradiation (Fig. 2e) . Thus, HCLK2 is required to efficiently inhibit replication-fork progression in response to DNA damage [20] [21] [22] [23] [24] [25] [26] [27] [28] . HCLK2 is required for activation of the Fanconi anaemia pathway after replication stress It is known that the S-phase checkpoint facilitates damage-induced monoubiquitination of FANCD2 and recruitment to sites of replication stress 29, 30 . In untreated control, ATR or HCLK2 siRNA cells, FANCD2 was present mainly in a nonubiquitinated form (FANCD2-S; Fig. 3a) . After hdroxyurea or Mitomycin C (MMC) treatment, cells transfected with control siRNA exhibited damage-induced FANCD2 monoubiquitination as revealed by the increase in the level of the FANCD2-L isoform relative to FANCD2-S (Fig. 3a) . In contrast, hydroxyurea treatment of cells transfected with ATR or HCLK2 siRNA failed to significantly induce FANCD2 monoubiquitination ( Fig. 3a and see Supplementary  Information, Fig. S1d) . Surprisingly, depletion of Chk1 led to a tenfold elevation in the basal level of the FANCD2-L isoform in untreated cells, relative to the control (Fig. 3b) . Following hydroxyurea treatment, the levels of the FANCD2-L isoform were not further induced in the absence of Chk1 (ref. 31) . HCLK2 seems to function upstream of Chk1, as simultaneous depletion of HCLK2 and Chk1 resulted in a fivefold reduction in the levels of the FANCD2-L isoform relative to the levels observed in cells depleted for Chk1 alone (Fig. 3c) .
Monoubiquitination is known to target FANCD2 to repair foci 32 . Cells transfected with control, ATR or HCLK2 siRNA display a similar basal level (20%) of untreated cells containing FANCD2 foci. In contrast, approximately 50% of untreated cells treated with Chk1 siRNA displayed FANCD2 foci (Fig. 3d, e) , consistent with the high basal levels of FANCD2 monoubiquitination (Fig. 3b) . In control siRNA cells, hydroxyurea or MMC treatment resulted in a dramatic induction in FANCD2 focus formation 18 h after treatment (Fig. 3d, e) . However, HCLK2 or ATR siRNA compromised both hydroxyurea-and MMC-induced FANCD2 focus formation (Fig. 3d, e) . Importantly, cell-cycle analysis indicated that the defect in damage-induced activation of FANCD2 in the absence of ATR or HCLK2 was not due to the accumulation of cells at a cell-cycle stage incompatible with FANCD2 monoubiquitination or focus formation (see Supplementary  Information, Fig. S3 ). Thus, HCLK2 is required for efficient damageinduced monoubiquitination and focus formation of FANCD2, similar to that previously reported for RPA, ATR and Nijmegen breakage syndrome (Nbs1)-deficient cells 29, 30 . To determine whether the role of HCLK2 in Fanconi anaemia-pathway activation is conserved, the contribution of clk-2 in the recruitment of the C. elegans homologue of FANCD2 (FCD-2) 33 to sites of replication stress was assessed. Two independently derived temperature-sensitive alleles of clk-2 (mn159 and qm37) remained intact for cisplatin and hydroxyurea-induced FCD-2 focus formation at the permissive temperature (15 °C; see Supplementary Information, Fig. S4b ). In contrast, cisplatin and hydroxyurea-induced FCD-2 focus formation was abolished in clk-2 mutants shifted to the non-permissive temperature (25 °C; Fig. 4a , b and see Supplementary Information, Fig. S4b) , and was also compromised in atl-1 (ATR) mutants and in animals subjected to rpa-1 RNA interference (RNAi), consistent with recent data from mammalian cells 29, 30 . However, clk-1, clk-3 or tim-1 mutants that encode biological clock proteins and the Timeless protein, respectively, displayed wild-type levels of FCD-2 foci following replication stress (Fig. 4a, b) .
These data reveal a conserved role for RPA-1, ATL-1 and CLK-2 in promoting FCD-2 focus formation in response to replication stress -a role not shared by all biological clock proteins.
It is known that cells deficient for FANCD2 monoubiquitination and assembly into repair foci are rendered sensitive to interstrand crosslink (ICL)-inducing agents 7, 33 . Indeed, cells depleted for HCLK2 or ATR were hypersensitive to the cytotoxic effects of MMC when compared with control cells (Fig. 4c) . Moreover, C. elegans clk-2 mutants also exhibited sensitivity to ICL-inducing agents, whereas clk-3 mutants displayed wild-type sensitivity (Fig. 4d) . Interestingly, clk-2; fcd-2 double mutants did not exhibit synergistic sensitivity to ICL-inducing agents, indicating that clk-2 and fcd-2 function in a common repair pathway (Fig. 4e) . Taken together, these data indicate that HCLK2 and its C. elegans counterpart have a conserved role in facilitating ICL repair.
HCLK2 regulates homologous-recombination repair after replication stress
It has been shown that Chk1 activation is required for homologousrecombination repair at sites of replication stress 34 , but it is unclear whether this function is also shared by other components of the Sphase checkpoint. Rad51 foci were present at low levels in a subset
Percentage of untreated control, ATR, HCLK2 and Chk1 siRNA cells (Fig. 5a, b) . After hydroxyurea or MMC treatment, Rad51 foci were induced in control siRNA cells, with 31.4% and 39.2% of cells within the population showing extensive Rad51 focus formation, respectively (Fig. 5a, b) . However, hydroxyurea and MMC treatment failed to induce Rad51 foci after treatment with ATR, HCLK2 or Chk1 siRNA (Fig. 5a, b) , which was not due to decreased Rad51 protein levels in ATR or HCLK2-depleted cells (Fig. 5d) . We also used a homologous recomination-reporter assay in SW480sn3 cells that measures homologous-recombination frequencies in an integrated neomycin plasmid [34] [35] [36] [37] . HCLK2 or Chk1 siRNAdepleted SW480sn3 cells produced neo resistant (neo R ) recombinants at a frequency greater than fourfold lower than the control siRNAtreated cells (Fig. 5c) . Furthermore, simultaneous siRNA depletion of HCLK2 and Chk1 did not confer an additive homologous-recombination defect, as the frequency of homologous-recombination events was equivalent to that observed in cells depleted for either HCLK2 or Chk1 alone (data not shown). Taken together, these data suggest that HCLK2 and Chk1 function in the same pathway to promote Rad51 recruitment and homologous recombination-mediated repair in response to replication stress.
Chk1 instability compromises claspin phosphorylation and Cdc25A degradation in the absence of HCLK2
To examine the cause of the checkpoint defect in HCLK2-depleted cells, we assessed the integrity of responses downstream of ATR recruitment, including Chk1 Ser 345 phosphorylation, Chk2 Thr 68 phosphorylation, claspin phosphorylation and Cdc25A degradation 26, 37, 38 . No detectable Chk1 phosphorylation at Ser 345 was observed in untreated control, ATR or HCLK2 siRNA cells (Fig. 6a) . However, control cells treated with hydroxyurea exhibited robust Chk1 phosphorylation at Ser 345 (Fig. 6a) . In contrast, Chk1 phosphorylation at Ser 345 was markedly reduced in ATR or HCLK2-depleted cells after hydroxyurea treatment, which in the case of HCLK2, was not due to a defect in phosphorylation, but was caused by an overall reduction in total Chk1 protein levels (Fig. 6a) . The mobility shift induced by claspin phosphorylation observed in control siRNA treated cells was also compromised following ATR or HCLK2 siRNA (Fig. 6a ) [39] [40] [41] . Furthermore, Cdc25A, which controls mitotic entry and is targeted for degradation in control cells in response to replication stress by Chk1-mediated phosphorylation 3 , was not efficiently degraded after hydroxyurea-treatment in cells treated with HCLK2 siRNA (Fig. 6b) . However, Chk2 Thr 68 phosphorylation in response to hydroxyurea-treatment remained intact in control, ATR and HCLK2 siRNA (Fig. 6c) . Taken together, these data indicate that HCLK2 is required for claspin phosphorylation and Cdc25A degradation in response to replication stress.
It was noted that the total Chk1 protein levels in HCLK2-depleted cells varied between experiments, with levels ranging from 40-80% of those observed in control cells (Fig. 6a and see Supplementary Information,  Fig. S1d-f) . This is likely because of fluctuations in the levels of spontaneous replication stress within asynchronous cell-culture populations treated with HCLK2 siRNA (Fig. 2) . Importantly, this phenotype was observed with two individual HCLK2 siRNAs (see Supplementary  Information, Fig. S1d) , and was not caused by an off-target effect of HCLK2 siRNA on Chk1 mRNA as similar transcript levels were present in control and HCLK2 siRNA cells before and after hydroxyurea treatment (Fig. 7a) . Similarly to endogenous Chk1, depletion of HCLK2 also significantly reduced the levels of transfected Flag-Chk1 relative to controls (Fig. 7b) . It has been previously shown that Chk1 is subjected to proteasome-dependent degradation following replication stress 42 . Timecourse analyses revealed that the overall rate of Chk1-protein degradation between 0 and 8 h after hydroxyurea treatment was increased 2.8 ± 0.6-fold (P = 0.002; calculated from three independent experiments) in HCLK2-depleted cells relative to control cells. At early time points after hydroxyurea-treatment (0 and 2 h) the rate of Chk1 degradation was increased 4.5 ± 0.5-fold in the absence of HCLK2 (Fig. 7c and see Supplementary Information, Fig. S1e ).
As it has been shown that ATR-mediated phosphorylation of Chk1 at Ser 345, but not at Ser 317, targets Chk1 for proteasome dependent degradation 42 , we assessed the impact of inactivation of ATR, or mutation of Chk1 at Ser 317 or Ser 345, on the levels of Chk1 present in HCLK2-depleted cells. Analogous to wild-type Chk1, levels of transfected Myc-Chk1 mutated at Ser 317 were reduced in HCLK2-depleted cells, but not after treatment with control siRNA (Fig. 7d) . However, transfected Myc-Chk1 mutated at Ser 345 that is resistant to ubiquitin dependent degradation 42 was not significantly reduced after hydroxyurea treatment in control or HCLK2 siRNA-treated cells (Fig. 7d) . Furthermore, simultaneous depletion of ATR and HCLK2 restored Chk1 to levels approaching those observed in cells treated with control or ATR siRNA (Fig. 7e) . Collectively, these data suggest that HCLK2 is required for Chk1 stability in unperturbed cells and protects Chk1 from rapid ubiquitin-dependent degradation following the induction of replication stress (Fig. 8) .
DISCUSSION
Studies in C. elegans have suggested a role for the biological clock protein CLK-2 in checkpoint responses to DNA damage 12, 13 . Before this study, it was not known how CLK-2 contributed to the DDR or whether its putative homologues in complex eukaryotes performed a similar function in DDR pathways. Here, we demonstrate that HCLK2 associates with ATR, ATRIP, claspin and Chk1, and is essential for many aspects of the S-phase checkpoint in mammalian cells: first, cells lacking HCLK2 accumulate spontaneous DNA damage in Sphase and exhibit abnormal mitoses analogous to ATR, Chk1 and TopB1-deficient cells 17, 43 . This suggests that HCLK2 has an important function in promoting replication fork stability and/or progression, and prevents mitotic entry in the presence of DNA damage. Second, . Average Chk1 protein levels quantified from western blots of two independent experiments using Biorad geldoc quantity-one software relative to wild-type Myc-Chk1 levels in control siRNA cells are shown (also see Supplementary Information,  Fig. S1f) . (e) Western blotting for the indicated proteins in extracts derived from control, ATR, HCLK2 and ATR + HCLK2 siRNA-treated HeLa cells. Quantification of Chk1 protein levels from three independent experiments is shown in the graph. The error bars represent s.e.m.
HCLK2-deficient cells exhibit an RDS phenotype indicating that HCLK2 also functions in orchestrating the S-phase checkpoint response after exposure to DNA-damaging agents. Third, HCLK2 is required for damage-induced monoubiquitination and subsequent recruitment of FANCD2 to sites of replication stress, analogous to ATR 29, 30 . Failure to activate and recruit FANCD2 in the absence of HCLK2 also confers sensitivity to ICL-inducing agents, a hallmark of Fanconi anaemia-deficient cells. Finally, activation of homologous recomination-mediated repair through Rad51 recruitment to sites of replication stress also requires ATR and HCLK2. This result is consistent with previous studies showing that phosphorylation of Rad51 on Thr 309 by Chk1 is important for activation of homologous recombination-mediated repair after replication stress 34 . Collectively, the failure to stabilize stalled replication forks, to respond to DNA damage in S-phase and to recruit FANCD2 and Rad51 to sites of replication stress indicates that HCLK2 has a critical function in maintenance of genome stability as part of the S-phase checkpoint 44 . Although HCLK2 interacts with ATR-ATRIP, the observation that HCLK2-deficient cells exhibit increased levels of spontaneous RPA32, γH2AX, BRCA1-mediated ubiquitin and ATR foci indicates that HCLK2 is largely dispensable for ATR-ATRIP recruitment and subsequent activation (Fig. 8) . Our data indicate that HCLK2 is also dispensable for Chk1 phosphorylation, but is required to maintain Chk1 stability; HCLK2-deficient cells display reduced Chk1 protein levels in unperturbed cells and exhibit an accelerated rate of proteasome-mediated Chk1 degradation when replication stress is further induced after hydroxyurea treatment. Consistent with a recent report that ATR-mediated phosphorylation of Chk1 at Ser 345 not only activates Chk1 but also targets it for ubiquitin dependent degradation 42 , we have shown that depletion of ATR or Chk1 mutated at Ser 345 but not at Ser 317 partially restores Chk1 protein levels in HCLK2-depleted cells. This suggests that elevation in response to spontaneous replication stress in HCLK2-depleted cells triggers ATR-dependent phosphorylation of Chk1 at Ser 345 and leads to proteasome-mediated degradation and reduced levels of Chk1. After hydroxyurea treatment, the reduced levels of Chk1 in HCLK2-depleted cells, coupled with an accelerated rate of Chk1 degradation, leads to a reduced capacity to trigger claspin phosphorylation and Cdc25A degradation necessary for efficient S-phase checkpoint activation, and also compromises Rad51 recruitment required to promote homologous recombinationmediated repair (Fig. 8) .
Our data also establish that damage-induced activation of the Fanconi anaemia pathway requires both ATR and HCLK2 (Fig. 3) , but surprisingly this function is independent of their roles in regulating Chk1 -depletion of Chk1 results in constitutive monoubiquitination and recruitment of FANCD2 to chromatin-associated foci (Fig. 3) . The observation that simultaneous depletion of Chk1 and HCLK2 suppresses constitutive Fanconi anaemia-pathway activation implies that HCLK2 functions upstream of Chk1 in regulating this pathway. It is therefore possible that ATR and HCLK2 are required to switch the Fanconi anaemia pathway on in response to replication stress, whereas Chk1 maybe required to downregulate the pathway once DNA integrity is restored. How ATR, HCLK2 and Chk1 control Fanconi anaemia-pathway function remains unclear, yet it is intriguing that the Fanconi anaemia core-complex components FANCA, FANCD2 and FANCM are phosphorylated in response to DNA damage 7 .
Our observation that HCLK2 and Chk1 weakly interact raises the possibility that HCLK2 may directly regulate Chk1 stability. However, it remains to be determined whether this interaction is direct, and as HCLK2 and its homologues lack any known motifs, it is unclear how HCLK2 might perform this function. In future studies it will be important to determine whether HCLK2 binds specifically to Chk1 pSer 345 or ubiquitinated Chk1 pSer 345, and if so, whether this association temporarily prevents access of the E3 ubiquitin ligase for Chk1 or the 26S proteasome. Our data indicate that similarly to Chk1, HCLK2 is a nuclear protein and was not detectably recruited or retained at sites of DNA damage (see Supplementary  Information, Fig. S4 ). Moreover, HCLK2 lacks conserved Ser-Glu motifs that may be targets for ATR phosphorylation. Indeed, no obvious mobility shift of HCLK2 was observed after DNA damage ( Fig. 1-7) . However, it is intriguing that HCLK2 protein levels noticeably decreased 6-8 h after replication stress, at the time when Chk1 protein levels also began to decrease in control cells (Fig. 7c) . It is therefore possible that Chk1 and HCLK2 are coordinately degraded by the proteasome to promote checkpoint termination, but how this is controlled remains unclear.
The observation that HCLK2-depleted cells share many phenotypic abnormalities with cells derived from Fanconi anaemia and Seckel syndrome patients raises the possibility that HCLK2 may be inactivated in human disease. This may manifest as a hypomorphic mutation similar to ATR mutations associated with Seckel syndrome 45 . Thus, assessing the integrity of the HCLK2 gene in Fanconi anaemia and Seckel cells that cannot be assigned to known complementation groups will be of great clinical importance. Immunoprecipitation conditions. Approximately 1 × 10 6 monolayered HeLa cells were washed with PBS and lysed on ice in 1 ml buffer containing 20 mM Tris at pH 8.0, 150 mM NaCL, 0.5% NP40, 1 mM EDTA, with protease and phosphatase inhibitor cocktails (P2714 & P5726, Sigma) and 50 U ml -1 benzonase (Novagen, Madison, WI) to digest RNA and DNA to eliminate non-specific interactions bridged by DNA and/or RNA. After centrifugation, supernatants were incubated with appropriate antibodies for 1 h before a mixture of protein A and protein G beads were added and the mixture incubated overnight at 4 °C. Beads were then pelleted and washed three times in 20× bed volume of the above buffer (excluding benzonase). Finally, 30 μl 2× SDS sample buffer containing reducing agent was added and the beads were boiled for 5 min. For gel loading, samples were centrifuged to pellet beads and 5 μl of supernatant was added per lane. Inputs represent 1/20 th of the extract used for the immunoprecipitation.
Cell-cycle analysis. Treated cells were washed once with PBS, trypsinized, washed again in PBS and then resuspended in 500 μl cell-cycle test Plus buffer (BD Biosciences, Stockholm, Sweden). Cell-cycle distribution was analysed by a FACSCalibur flow cytometer (BD Bioscience) using Cellquest software. ModFit programme was used to analyse the cell-cycle profiles (Verity Software House Inc., Topsham, ME).
Real-time PCR analysis of mRNA levels. siRNA and hydroxyurea treatments were performed on HeLa cells as previously described. RNA preparations were made using the Qiagen RNeasy mini kit, according to the manufacturer's protocol, and subsequently digested with TURBO DNase (Ambion, Austin, TX) following the method for rigorous treatment. Total RNA (1 μg) was converted to cDNA using the Superarray first strand cDNA synthesis kit, according to the manufacturer's protocol. These cDNA samples were then diluted 1:5 for real-time PCR, using the Superarray SYBR green/ROX RT Sigma PCR master mix and RT 2 primer sets for KIAA0683 (HCLK2), CHEK1 and ACTG1 (actin). Reactions were performed in triplicate using a two-step cycling program (10 min, 95 °C; 40 cycles of 15 s, 95 °C and 1 min, 60 °C; and terminal dissociation protocol) on an ABI Prism 7000 sequence-detection system. Standard curves were produced for each primer set using control cDNA, and all PCR reactions were repeated using appropriately diluted RNA to preclude cellular DNA contamination. Threshold cycle values for each reaction were determined using the ABI Prism software, and converted to a relative expression level according to the straight-line equation obtained from plotting the standard curve threshold cycles against the log template dilution factor. Relative expression levels for each reaction were then normalized to actin levels in the equivalent cDNA sample.
Homologous-recombination assay. Measurement of the frequency of homologous recombination-mediated DSB repair was performed as previously described. Briefly, the assay was performed in SW480sn3 cells that contain a single integrated copy of an SCneo substrate 35 . After transfection (48 h) of SW480sn3 cells with control, HCLK2 or Chk1 siRNAs, cells were further transfected with an ISce-1 expression plasmid, and were either plated in regular media (500 per dish in triplicate) or in media containing 1 mg ml -1 G418 (100,000 per dish in triplicate). After two weeks incubation, the media was removed and colonies stained with Geimsa, washed and counted. The recombination frequency was calculated as follows: the numbers of colonies (containing more than 50 cells) present on nonselected plates was divided by the number plated to give the plating efficiency. This number was multiplied by the number of cells plated on G418-selected plates to give the 'expected' number of colonies. The actual number of colonies present on G418 plates was then divided by the expected number to calculate recombination frequency. Each recombination frequency was multiplied by 1000 to give a number suitable for graphical representation. For all siRNA-treated cells (control, Chk1, HCLK2 and Chk1-HCLK2), a replica set of cells were not transfected with the ISce-1 plasmid and equal numbers of cells were then plated in non-G418 and G418-containng media. No colonies grew on any of these dishes indicating that any colonies presented on the ISce-1-tranfected cells were because of recombination of the G418 gene and not due to background and/or chance recombination events. and two single HCLK2 (+) siRNAs (HCLK2_1 and HCLK2_2) before and 2 hours after treatment with 3 mM HU E. Western blotting with the indicated antibodies of extracts derived from control (-) and HCLK2 (+) siRNA treated cells before and at the indicated time points after treatment with 3 mM HU. F. Western blotting for transfected Myc-Chk1, HCLK2 and actin following transfection with Myc-Chk1 wild type, S317A, or S345A alleles, 48 hours after control or HCLK2 siRNA treatments. The indicated levels of MycChk1 were quantified using Biorad geldoc quantity-one software, and are expressed relative to the levels in control cells. 
